West Pharmaceutical Services, Inc. (WST)
NYSE: WST · Real-Time Price · USD
415.65
-2.15 (-0.51%)
Nov 17, 2026, 10:44 AM EST - Market open

WST Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
28,95519,79523,72326,05317,42434,744
Market Cap Growth
53.99%-16.56%-8.95%49.53%-49.85%65.89%
Enterprise Value
28,80419,46923,54025,46116,99534,372
Last Close Price
417.80274.33325.54349.11232.80462.80

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
46.6940.0948.1543.9129.7452.50
Forward PE
41.8736.6945.9042.2334.8453.55
PS Ratio
8.576.448.208.836.0412.27
PB Ratio
9.826.238.849.046.4914.88
P/TBV Ratio
10.206.479.259.456.8115.78
P/FCF Ratio
64.2042.2285.8362.8639.65105.09
P/OCF Ratio
44.4726.2336.3133.5524.0759.49
PEG Ratio
2.723.065.255.392.312.37

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
8.526.338.148.635.8912.14
EV/EBITDA Ratio
30.1224.0331.4330.1919.2238.58
EV/EBIT Ratio
37.2730.4839.6636.0522.2544.72
EV/FCF Ratio
63.8641.5285.1761.4338.68103.97

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.110.100.110.110.120.14
Debt / EBITDA Ratio
0.310.380.390.350.350.36
Debt / FCF Ratio
0.690.701.110.750.720.98
Net Debt / Equity Ratio
-0.05-0.15-0.07-0.19-0.21-0.19
Net Debt / EBITDA Ratio
-0.16-0.57-0.24-0.65-0.65-0.49
Net Debt / FCF Ratio
-0.33-0.99-0.65-1.31-1.31-1.32
Asset Turnover
0.830.780.770.790.830.93
Inventory Turnover
4.704.804.674.284.414.73
Quick Ratio
1.912.101.932.072.732.13
Current Ratio
2.823.022.802.883.702.93
Return on Equity (ROE)
21.23%16.86%17.71%21.32%23.34%31.59%
Return on Assets (ROA)
11.89%10.09%9.93%11.86%13.78%15.73%
Return on Invested Capital (ROIC)
21.62%19.66%20.14%26.35%31.89%38.14%
Return on Capital Employed (ROCE)
22.70%17.70%19.20%22.40%24.70%28.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
2.14%2.49%2.08%2.28%3.36%1.91%
FCF Yield
1.56%2.37%1.17%1.59%2.52%0.95%
Dividend Yield
0.25%0.31%0.25%0.22%0.31%0.15%
Payout Ratio
10.33%12.40%12.00%9.61%9.23%7.72%
Buyback Yield / Dilution
1.48%1.36%2.13%0.66%0.66%-0.66%
Total Shareholder Return
1.73%1.67%2.37%0.88%0.97%-0.51%
SEC Filings: 10-K · 10-Q